P950-0537 Screening compound: 3-[8-(4-pyridylcarbonyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidin-2-yl]benzonitrile

P950-0537 Screening compound: 3-[8-(4-pyridylcarbonyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidin-2-yl]benzonitrile
P950-0537 Screening compound: 3-[8-(4-pyridylcarbonyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidin-2-yl]benzonitrile alternative view

Chemical Structure Depiction of ChemDiv screening compound P950-0537
3-[8-(4-pyridylcarbonyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidin-2-yl]benzonitrile

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P950-0537

Molecular Formula

C19H15N5O (C19 H15 N5 O)

Compound Name

3-[8-(4-pyridylcarbonyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidin-2-yl]benzonitrile

IUPAC name

3-[8-(pyridine-4-carbonyl)-5H6H7H8H-imidazo[12-a]pyrimidin-2-yl]benzonitrile

SMILES

N#Cc1cccc(-c2cn(CCCN3C(c4ccncc4)=O)c3n2)c1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

329.36

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.057

Distribution Coefficient, logD

2.057

Water Solubility, LogSw

-1.96

Polar Surface Area

53.366

Acid Dissociation Constant (pKa)

21.73

Base Dissociation Constant (pKb)

3.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.79

P950-0537 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Cancer
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P950-0537 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P950-0537?
Check Price and Availability of P950-0537, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P950-0537 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P950-0537
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P950-0537
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P950-0537 available by request